|
시장보고서
상품코드
2039035
계절성 정서 장애 시장 : 유형별, 치료법별, 최종사용자별, 지역별Seasonal Affective Disorder Market, By Type, By Treatment, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
계절성 정서 장애 시장은 2026년에 187억 달러로 추정되며, 2033년까지 256억 달러에 이를 전망입니다. 또한 2026-2033년 CAGR은 8.3%를 나타낼 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 187억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 8.30% | 예측 금액(2033년) | 256억 달러 |
계절성 정서장애는 특정 시기나 계절에 발병하는 우울증의 일종입니다. 계절의 변화는 기분과 활력에 큰 영향을 미치며, 일상생활에 심각한 지장을 초래하는 우울증 증상을 유발합니다.
시장 역학
계절성 정서장애 발병률 증가는 예측 기간 동안 SAD 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, Hindawi Publishing Corporation의 『Depression Research and Treatment』지가 2015년 12월에 발표한 논문에 따르면, 적도에서 가장 멀리 떨어진 북위 고위도 지역에 사는 사람들이 SAD에 가장 취약한 것으로 보고되고 있습니다. 보고된 바 있습니다. 예를 들어, 미국에서는 플로리다 거주자의 1.4%, 알래스카 거주자의 9.9%가 계절성 정서장애를 경험하고 있습니다.
그러나 부프로피온 등 계절성 정서장애 치료제의 부작용이 시장 성장을 저해할 것으로 예측됩니다. 예를 들어, 미국 국립생물공학정보센터(NCBI)가 2020년 10월 발표한 기사에 따르면, 미국 식품의약국(FDA)에 승인된 부프로피온이라는 약물에는 빈맥(심혈관 질환), 비염, 인두염(호흡기 질환) 등의 부작용이 보고된 바 있습니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 계절성 정서 장애 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 작성되었습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 계절성 정서 장애 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 유통업체, 신규 참가자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 계절성 정서장애 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 계절성 정서 장애 시장 : 유형별(2021년-2033년)
제5장 세계의 계절성 정서 장애 시장 : 치료법별(2021년-2033년)
제6장 세계의 계절성 정서 장애 시장 : 최종사용자별(2021년-2033년)
제7장 세계의 계절성 정서 장애 시장 : 지역별(2021년-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.06.04Seasonal Affective Disorder Market is estimated to be valued at USD 18.7 Bn in 2026 and is expected to reach USD 25.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 25.6 Bn |
Seasonal affective disorder (SAD) is a form of depression that people experience at a particular time of year or during a particular season. The change in the season highly affects the mood and energy levels, and lead to symptoms of depression that have a significant impact on day-to-day life.
Market Dynamics
Rising incidence of seasonal affective disorder (SAD) is expected to drive seasonal affective disorder market growth over the forecast period. For instance, according to an article published by the Hindawi Publishing Corporation-Depression Research and Treatment, in December 2015, reports that the people who lives farthest from the equator in northern latitudes are most susceptible towards SAD, for instance, in the U.S., 1.4% of those who live in Florida and 9.9% living in Alaska experience seasonal affective disorder.
However, side effects of seasonal affective disorder medication such as Bupropion is expected to hinder the market growth. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in October 2020, reports that the drug Bupropion, which is approved by the U.S. FDA exhibit several side effects such as tachycardia (cardiovascular disease), rhinitis and pharyngitis (respiratory diseases), and others.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global seasonal affective disorder market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., AbbVie, Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Mylan, Inc., Bausch Health, Koninklijke Philips N.V., Bayer AG, Allergan, Bristol-Myers Squibb, and Henry Schein Inc. among others
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global seasonal affective disorder market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global seasonal affective disorder market.
Seasonal Affective Disorder Market Segmentation
- By Type (Revenue, USD Bn, 2021-2033)
- Fall & Winter Seasonal Affective Disorder
- Spring & Summer Seasonal Affective Disorder
- Others
- By Treatment (Revenue, USD Bn, 2021-2033)
- Light Therapy, Medications
- Psychotherapy
- Counselling
- Others
- By End User: (Revenue, USD Bn, 2021-2033)
- Hospitals
- Clinics
- Research Institutes
- Others
- By Region: (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Pfizer, Inc
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc
- Novartis AG
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Eli Lily and Company
- AbbVie Inc
- Hoffmann-La Roche AG
- Mylan, Inc
- Bausch Health
- Koninklijke Philips N.V.
- Bayer AG
- Allergan
- Bristol-Myers Squibb
- Henry Schein Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
4. Global Seasonal Affective Disorder Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Fall & Winter Seasonal Affective Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Spring & Summer Seasonal Affective Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Seasonal Affective Disorder Market, By Treatment, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Light Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Psychotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Counselling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Seasonal Affective Disorder Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Seasonal Affective Disorder Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
- Market Size and Forecast, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Pfizer, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson Services Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lily and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch Health
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Koninklijke Philips N.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allergan
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol-Myers Squibb
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Henry Schein Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Pfizer, Inc
9. Section
- References
- Research Methodology
- About us and Sales Contact
